BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3788753)

  • 1. L-carnitine: its therapeutic potential.
    DiPalma JR
    Am Fam Physician; 1986 Dec; 34(6):127-30. PubMed ID: 3788753
    [No Abstract]   [Full Text] [Related]  

  • 2. Carnitine.
    Borum PR
    Annu Rev Nutr; 1983; 3():233-59. PubMed ID: 6357236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case history of myopathic carnitine deficiency benefited by glucocorticoids and L-carnitine supplementation.
    Howard LJ; Beckerman AH
    Drug Nutr Interact; 1985; 3(4):191-6. PubMed ID: 4064927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of supplementation of L-carnitine in the dialysate of patients treated with acetate hemodialysis.
    Guarnieri G; Toigo G; Crapesi L; Situlin R; Del Bianco MA; Corsi M; Lo Greco P; Vasile A
    Kidney Int Suppl; 1989 Nov; 27():S247-55. PubMed ID: 2636666
    [No Abstract]   [Full Text] [Related]  

  • 5. Bicarnesine-treated carnitine deficient myopathy: clinico-chemical investigations.
    László A; Klujber L; Svékus A
    Acta Paediatr Hung; 1992; 32(3):235-9. PubMed ID: 1476782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carnitine deficiency myopathy (author's transl)].
    Jerusalem F
    Nervenarzt; 1980 May; 51(5):266-71. PubMed ID: 7007897
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of myopathic carnitine deficiency: quantitation of response to prednisone and carnitine.
    Griggs RC; Pandya S; Moxley RT; Forbes G; VanDyke DH; Pearce FJ
    Trans Am Neurol Assoc; 1981; 106():199-202. PubMed ID: 7348994
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary carnitine deficiency in a male adult.
    Karmaniolas K; Ioannidis P; Liatis S; Dalamanga M; Papalambros T; Migdalis I
    J Med; 2002; 33(1-4):105-10. PubMed ID: 12939109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carnitine in normal subjects and in pathology].
    Odièvre M
    Arch Fr Pediatr; 1984 Dec; 41(10):721-6. PubMed ID: 6398040
    [No Abstract]   [Full Text] [Related]  

  • 10. Dialysis-related carnitine disorder.
    Hedayati SS
    Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-carnitine supplementation in patients with cystic acne on isotretinoin therapy.
    Georgala S; Schulpis KH; Georgala C; Michas T
    J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):205-9. PubMed ID: 10642057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral treatment of carnitine myopathy.
    Hosking GP; Cavanagh NP; Smyth DP; Wilson J
    Lancet; 1977 Apr; 1(8016):853. PubMed ID: 67353
    [No Abstract]   [Full Text] [Related]  

  • 14. L-carnitine in dialysed patients: the choice of dosage regimen.
    Berard E; Iordache A; Barrillon D; Bayle J
    Int J Clin Pharmacol Res; 1995; 15(3):127-33. PubMed ID: 8847154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
    Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary carnitine deficiency: adult onset lipid storage myopathy with a mild clinical course.
    Vielhaber S; Feistner H; Weis J; Kreuder J; Sailer M; Schröder JM; Kunz WS
    J Clin Neurosci; 2004 Nov; 11(8):919-24. PubMed ID: 15519880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial carnitine deficiency].
    Yorifuji S
    Ryoikibetsu Shokogun Shirizu; 2001; (36):47-50. PubMed ID: 11596440
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy.
    El-Beshlawy A; Youssry I; El-Saidi S; El Accaoui R; Mansi Y; Makhlouf A; Taher A
    Pediatr Hematol Oncol; 2008 Dec; 25(8):734-43. PubMed ID: 19065439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carnitine-deficient myopathy successfully treated with bicarnesine; clinico-chemical and muscle morphology studies].
    László A; Klujber L; Svékus A
    Orv Hetil; 1986 Mar; 127(13):777-9. PubMed ID: 3703543
    [No Abstract]   [Full Text] [Related]  

  • 20. Thirty-year follow-up of carnitine supplementation in two siblings with hypertrophic cardiomyopathy caused by primary systemic carnitine deficiency.
    Kishimoto S; Suda K; Yoshimoto H; Teramachi Y; Nishino H; Koteda Y; Itoh S; Kudo Y; Iemura M; Matsuishi T
    Int J Cardiol; 2012 Aug; 159(1):e14-5. PubMed ID: 22154200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.